GCF Levels of IL-1β and IL-6 in Gingivitis and Stage III-Grade C Periodontitis

Periodontitis Clinical Trial

Official title: Usak University Faculty of Dentistry

Status Completed

Clinical Trial Summary

Periodontal diseases are chronic diseases that occur as a result of a violation of the balance between microbial dental plaque and the host response. Gingivitis is a disease characterized by inflammation of the gingiva that occurs in one or more areas without loss of attachments.1 in periodontitis, an inflammatory event that begins in the gingiva along with gingivitis spreads to the periodontal ligament, alveolar bone and soft tissues that support the tooth, causing the destruction of these structures.2 Cytokines are low molecular weight proteins that participate in the initial and active stages of inflammation and immunity. In periodontal disease pathogenesis, cytokine response has been reported to play a very critical role in determining disease progression.3 IL-1beta and IL-6 are key cytokines in chronic inflammatory diseases and have the potential to initiate bone loss and tissue destruction seen in periodontal disease.4the purpose of this study; it is to determine the degree of inflammation and periodontal destruction by determining the levels of IL-1beta and IL-6 cytokines in the gingival crevicular fluid of periodontal healthy and diseased individuals.

Clinical Trial Description

Periodontal measurement were done at 6 sites per tooth After clinical evaluation, individuals were divided into 3 groups 1. Healthy control groups: clinically healthy gingiva 2. Gingivitis groups: BOP score of 10% or greater and PD≤3mm 3. Periodontitis groups: AL ≥5 mm, PD≥6 mm and tooth loss due to periodontitis of ≤4. GCF samples were collected using strips. ;

Related Conditions & MeSH terms

• Gingivitis
• Periodontitis

• NCT number: NCT04689438
• Study type: Observational
• Source: Usak University
• Status: Completed
• Start date: October 8, 2020
• Completion date: December 28, 2020